San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Zerigo Health is raising $43,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, John Schellhorn played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Zerigo Health
Zerigo Health is a private San Diego-based medical device company focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions. The Clarify System, cleared by FDA in 2017, is indicated for localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patients own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patients physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress and satisfaction.

To learn more about Zerigo Health, visit http://www.zerigohealth.com/

Contact:
John Schellhorn, Chief Executive Officer
877-738-6041
https://www.linkedin.com/in/john-schellhorn-57a6998/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved